In this study, the effect of moderate endurance training on muscle morphological properties of human thigh muscles and isokinetic strength was examined. Five sedentary females carried out a training program of 30 min./day, 3 times a week for a ten-week period. The load requirement was set to 60% of maximal aerobic capacity (Vo₂max) of the subjects. In the determination of muscle cross-sectional areas (CSAs) by MRI, longitudinal sections were first imaged, and ten axial images along the length of femur were taken before and after the endurance training. Muscle CSA and mus-cle volume of knee extensors (KE), flexors (KF), and adductors (AD) were calculated, using the ten axial images. Vo₂max was significantly increased after endurance training (14.6%, p<0.01) . Muscle CSA in KE was significantly increased at the ten levels of femur length. There were also significant increases at seven levels of femur length after endurance training in KF (p<0.05, and 0.01) . Percentage increase of msucle CSA in KE and KF were 10.9 to 16.5% and 7.7 to 15.8%, respectively. Although the muscle volume of KE, KF, and AD was significantly increased, no change in fat volume was observed after endurance training. Isokinetic knee extension and flexion peak torque and peak torque per unit of muscle CSA at three angular velocities (30, 180, and 300 deg/sec) didn't show significant changes. These results suggest that muscle hypertrophy induced by moderate endurance training has no effect on muscle strength.

In this study, the effect of moderate endurance training on muscle morphological properties of human thigh muscles and isokinetic strength was examined. Five sedentary females carried out a training program of 30 min./day, 3 times a week for a ten-week period. The load requirement was set to 60% of maximal aerobic capacity (Vo₂max) of the subjects. In the determination of muscle cross-sectional areas (CSAs) by MRI, longitudinal sections were first imaged, and ten axial images along the length of femur were taken before and after the endurance training. Muscle CSA and mus-cle volume of knee extensors (KE), flexors (KF), and adductors (AD) were calculated, using the ten axial images. Vo₂max was significantly increased after endurance training (14.6%, p<0.01) . Muscle CSA in KE was significantly increased at the ten levels of femur length. There were also significant increases at seven levels of femur length after endurance training in KF (p<0.05, and 0.01) . Percentage increase of msucle CSA in KE and KF were 10.9 to 16.5% and 7.7 to 15.8%, respectively. Although the muscle volume of KE, KF, and AD was significantly increased, no change in fat volume was observed after endurance training. Isokinetic knee extension and flexion peak torque and peak torque per unit of muscle CSA at three angular velocities (30, 180, and 300 deg/sec) didn't show significant changes. These results suggest that muscle hypertrophy induced by moderate endurance training has no effect on muscle strength.

Background/Aims: 5-Aminosalicylic acid (5-ASA) is a basic drug for inducing and maintaining remission for ulcerative colitis. One of its formulations has a coating with a pH-dependent degradation that ensures the release 5-ASA at the terminal ileum. No evidence has been shown concerning the effects of proton pump inhibitors (PPIs) or H2 receptor antagonists (H2RAs) on the clinical course of ulcerative colitis patients in remission. The present study assessed the effect of PPIs or H2RAs on the relapse of ulcerative colitis patients in clinical remission maintained by pH-dependent released 5-ASA. Methods: Ulcerative colitis patients who had been prescribed time- or pH-dependent-released 5-ASA between January 2015 and December 2018 were enrolled in this multicenter retrospective study. The period of remission until relapse occurred was analyzed among the patients taking time-dependent-released 5-ASA or pH-dependent-released 5-ASA with/without PPIs or H2RAs. Results: One hundred and nineteen patients were analyzed in this study. In the primary endpoint, the relapse rate was higher in patients taking pH-dependent-released 5-ASA and PPIs or H2RAs than in those taking the pH-dependent-released 5-ASA without PPIs or H2RAs, while the relapse rate was similar in patients taking the time-dependent-released 5-ASA with or without PPIs or H2RAs concomitantly. Patients with a short duration of disease and middle-aged patients more frequently showed relapse with PPIs or H2RAs than the other patients. Conclusions The coadministration of PPIs or H2RAs affects the clinical course of ulcerative colitis in remission maintained by pH-dependent-released 5-ASA.

Background/Aims: 5-Aminosalicylic acid (5-ASA) is a basic drug for inducing and maintaining remission for ulcerative colitis. One of its formulations has a coating with a pH-dependent degradation that ensures the release 5-ASA at the terminal ileum. No evidence has been shown concerning the effects of proton pump inhibitors (PPIs) or H2 receptor antagonists (H2RAs) on the clinical course of ulcerative colitis patients in remission. The present study assessed the effect of PPIs or H2RAs on the relapse of ulcerative colitis patients in clinical remission maintained by pH-dependent released 5-ASA. Methods: Ulcerative colitis patients who had been prescribed time- or pH-dependent-released 5-ASA between January 2015 and December 2018 were enrolled in this multicenter retrospective study. The period of remission until relapse occurred was analyzed among the patients taking time-dependent-released 5-ASA or pH-dependent-released 5-ASA with/without PPIs or H2RAs. Results: One hundred and nineteen patients were analyzed in this study. In the primary endpoint, the relapse rate was higher in patients taking pH-dependent-released 5-ASA and PPIs or H2RAs than in those taking the pH-dependent-released 5-ASA without PPIs or H2RAs, while the relapse rate was similar in patients taking the time-dependent-released 5-ASA with or without PPIs or H2RAs concomitantly. Patients with a short duration of disease and middle-aged patients more frequently showed relapse with PPIs or H2RAs than the other patients. Conclusions The coadministration of PPIs or H2RAs affects the clinical course of ulcerative colitis in remission maintained by pH-dependent-released 5-ASA.

PURPOSE: The aim of this study was to evaluate the validity and reliability of the Seattle Angina Questionnaire, Japanese version (SAQ-J) as a disease-specific health outcome scale in patients with coronary artery disease. METHODS: Patients with coronary artery disease were recruited from a university hospital in Tokyo. The patients completed self-administered questionnaires, and medical information was obtained from the subjects' medical records. Face validity, concurrent validity evaluated using Short Form 36 (SF-36), known group differences, internal consistency, and test-retest reliability were statistically analyzed. RESULTS: A total of 354 patients gave informed consent, and 331 of them responded (93.5%). The concurrent validity was mostly supported by the pattern of association between SAQ-J and SF-36. The patients without chest symptoms showed significantly higher SAQ-J scores than did the patients with chest symptoms in 4 domains. Cronbach's alpha ranged from .51 to .96, meaning that internal consistency was confirmed to a certain extent. The intraclass correlation coefficient of most domains was higher than the recommended value of 0.70. The weighted kappa ranged from .24 to .57, and it was greater than .4 for 14 of the 19 items. CONCLUSIONS: The SAQ-J could be a valid and reliable disease-specific scale in some part for measuring health outcomes in patients with coronary artery disease, and requires cautious use.
Asian Continental Ancestry Group ; Coronary Artery Disease ; Coronary Vessels ; Humans ; Informed Consent ; Medical Records ; Reproducibility of Results ; Thorax ; Tokyo ; Surveys and Questionnaires